https://www.selleckchem.com/products/takinib.html
392). Age, however, was a significant predictor of improved survival as analyzed by multivariate analysis (p = 0.024). SF-12 physical component scores demonstrated no significant change after treatment.Conclusions The CKSR is a non-invasive, safe, and effective modality in the treatment of patients with brainstem metastases of NSCLC. Better therapeutic outcomes of CKSR for brainstem metastasis might be achieved in the patients older than 65 years old.Purpose To investigate the physiological uptake of hybrid fluorine-18-fluorodeoxyglucos
Like
Comment
Share
